Teva Pharmaceutical Industries Ltd, an international pharmaceutical company, could be considering a takeover bid for acquiring Mylan NV, as per private sources within the company.

The merger would help to create a global generic-drug giant and would also increase sales for both companies. It has been said that Teva Pharmaceutical Industries Ltd is in internal debate over the takeover bid and no offer has materialized till date.

Advisers have been approached by the company about the possibility of such a bid transpiring and the financing needed for a try of this scale. Acquisition of acquisition is going to have a very high price tag for Teva Pharmaceutical Industries Ltd.

An unsolicited bid has been recently made by Mylan NV for acquiring Perrigo Company plc Ordinary Shares. According to experts, it has been expected that the end of such a bid for Mylan NV with Perrigo Company plc Ordinary Shares will help the two companies to have combined revenue of $15.3 billion.

There is a possibility that the Mylan NV bid for Perrigo Company plc Ordinary Shares may increase Teva Pharmaceutical Industries Ltd on making an offer before the price increase out of reach. Mylan NV said that they have no interest in such a deal and is concentrated on their discussions for acquiring Perrigo Company plc Ordinary Shares.

Up to now, Teva Pharmaceutical Industries Ltd has not said anything about the reports of their takeover bid. Teva Pharmaceutical Industries Ltd's share climbed 2.2% or $1.42 to total at $64.91 on Friday 17th April. A spike to 4.5% or $2.98 to $69.82 has also been seen in Mylan NV.